Vancomycin-resistant Staphylococcus aureus in Nepal: an impending crisis?

Emergence of Vancomycin Intermediate Staphylococcus aureus (VISA) and Vancomycin resistant Staphylococcus aureus (VRSA), though reported less frequently , is a serious matter of concern. It perhaps indicates the impending development and spread of VRSA posing the greatest risk to the patients and threat to the clinicians and microbiologists alike. Article by Chaudhary et al (2010) is interesting because it has brought out certain important findings to the scientific community in the Nepalese context from the microbiological perspective. This paper has reported VRSA, perhaps for the first time in Nepal and the proportion (18% VRSA, among the S. aureus isolates from the chronic dacryocystitis ) is really alarming.